美股A股
StockGist
Back
8-K2026-03-04· grok-4-1-fast-non-reasoning

LUNG · Pulmonx Corporation

0001127537-26-000003

SEC filing

Summary

Pulmonx Corporation reported Q4 2025 worldwide revenue of $22.6 million, down 5% from Q4 2024, and full year 2025 revenue of $90.5 million, up 8% from 2024, with net loss of $10.4 million and $54.0 million respectively. The company refinanced debt for up to $60 million under a 5-year facility maturing 2031 and issued 2026 guidance of $90-92 million revenue.

Key takeaways